Report
Damien Conover
EUR 100.00 For Business Accounts Only

Charles River Laboratories' 2Q Performance Tracks Our Expectations Amid Guidance Uplift

Charles River Laboratories' performance during the quarter tracked our expectations. We do not expect to change our fair value estimate, and we are maintaining our narrow moat rating. Management’s newly upgraded adjusted 2018 EPS guidance range to $5.85-$6.00 still encompasses our $5.89 estimate. The company’s uplifted guidance stems from a stronger revenue outlook, along with higher-than-expected gains from venture capital investments. We note that Charles River’s healthy funding environment fo...
Underlying
Charles River Laboratories International Inc.

Charles River Laboratories International is a contract research organization. The company has a laboratory animal medicine and science to develop a portfolio of discovery and safety assessment services. The company's segments are: Research Models and Services, which supplies research models to the drug development industry; Discovery and Safety Assessment (DSA), which provides DSA services, including in vitro and in vivo studies, laboratory support services, and strategic non-clinical consulting and program management to support product development; and Manufacturing Support, which ensures the production and release of products manufactured by the company's clients.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Damien Conover

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch